Mobile

A PHASE 2A RANDOMIZED, DOUBLE-BLINDED, DOUBLE DUMMY, PLACEBO AND ACTIVE CONTROLLED, TWO-WAY CROSS-OVER, FLARE-ENRICHED MULTI-CENTRE CLINICAL TRIAL TO EXAMINE THE PAIN RELIEF PRODUCED BY 2 WEEKS OF DAI...

Mise à jour : Il y a 4 ans
Référence : EUCTR2009-014734-16

A PHASE 2A RANDOMIZED, DOUBLE-BLINDED, DOUBLE DUMMY, PLACEBO AND ACTIVE CONTROLLED, TWO-WAY CROSS-OVER, FLARE-ENRICHED MULTI-CENTRE CLINICAL TRIAL TO EXAMINE THE PAIN RELIEF PRODUCED BY 2 WEEKS OF DAILY ORAL ADMINISTRATION OF A FATTY ACID AMIDE HYDROLASE (FAAH) INHIBITOR PF-04457845 IN PATIENTS WITH OSTEOARTHRITIS OF THE KNEE

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

•To evaluate the efficacy of PF-04457845 (administered QD) versus placebo in relieving pain in patients with osteoarthritis of the knee. •To evaluate the safety and tolerability of PF-04457845 in patients with osteoarthritis.

Critère d'inclusion

  • Osteoarthritis of the knee

Liens